glp-1 weight loss tablets Lilly launches pill, kicking off showdown with Novo Nordisk GLP-TRIM - A Natural GLP-1

Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year

In turn, those SCFAs signal cells in the gut to release GLP-1 into the bloodstream

And when protein drops, muscle follows

In 2025, advanced medical options like Endoscopic Sleeve Gastroplasty (ESG), bariatric surgery, and GLP-1 medications offer powerful support beyond lifestyle changes.

In new guidelines, the American Society of Anesthesiologists (ASA) and other professional groups recommend that most patients using glucagon-like peptide-1 (GLP-1) receptor agonists can continue their medication regimen prior to elective surgery

GLP-1 receptor agonists offer metabolic benefits but carry documented side effects, contraindications, and cost barriers